Dechra Pharmaceuticals (DPH) RNS Announcements

Add to Alert list
Date Time Source Announcement
20 Apr 2023 02:26 PM
BZW
Form 8.3 - Dechra Pharmaceuticals PLC
20 Apr 2023 01:28 PM
BZW
Form 8.3 - Dechra Pharmaceuticals PLC (DPH LN)
20 Apr 2023 11:28 AM
RNS
Form 8 (OPD) - Dechra Pharmaceuticals PLC
19 Apr 2023 12:38 PM
EQS
Dechra Pharmaceuticals plc
19 Apr 2023 07:00 AM
BZW
Form 8.3 - Dechra Pharmaceuticals PLC
18 Apr 2023 01:00 PM
EQS
Dechra Pharmaceuticals plc
18 Apr 2023 11:53 AM
RNS
Holding(s) in Company
17 Apr 2023 01:15 PM
EQS
Dechra Pharmaceuticals plc
17 Apr 2023 07:30 AM
BZW
Form 8.3 - Dechra Pharmaceuticals Plc
14 Apr 2023 02:44 PM
BZW
Form 8.3 - Dechra Pharmaceuticals PLC
13 Apr 2023 05:32 PM
RNS
Statement re Possible Offer
31 Mar 2023 10:50 AM
RNS
Total Voting Rights
15 Mar 2023 02:03 PM
RNS
Block listing Interim Review
28 Feb 2023 09:39 AM
RNS
Total Voting Rights
27 Feb 2023 07:00 AM
RNS
Half-year Report - six months to 31 December 2022
31 Jan 2023 08:54 AM
RNS
Total Voting Rights
12 Jan 2023 07:00 AM
RNS
Trading Update and Notice of Results
30 Dec 2022 07:00 AM
RNS
Total Voting Rights
20 Dec 2022 07:00 AM
RNS
Appointment of Geeta Gopalan as a NED
15 Dec 2022 02:55 PM
RNS
Holding(s) in Company
30 Nov 2022 11:00 AM
RNS
Total Voting Rights
31 Oct 2022 01:05 PM
RNS
Total Voting Rights
20 Oct 2022 02:45 PM
RNS
Result of AGM
20 Oct 2022 07:00 AM
RNS
AGM -Trading Update
13 Oct 2022 09:24 AM
RNS
Director/PDMR Shareholding
07 Oct 2022 04:26 PM
RNS
PDMR Shareholding -PCA
05 Oct 2022 04:20 PM
RNS
Holding(s) in Company
05 Oct 2022 04:16 PM
RNS
Holding(s) in Company
03 Oct 2022 08:21 AM
RNS
Total Voting Rights
26 Sep 2022 03:01 PM
RNS
Director/PDMR Shareholding
22 Sep 2022 03:43 PM
RNS
Director/PDMR Shareholding
20 Sep 2022 04:44 PM
RNS
Grant of award - Deferred Bonus Plan
20 Sep 2022 02:41 PM
RNS
Posting of 2022 Annual Financial Report
16 Sep 2022 08:28 AM
RNS
Holding(s) in Company
15 Sep 2022 03:28 PM
RNS
2022 Annual Report Posting Date
15 Sep 2022 12:13 PM
RNS
Block listing Interim Review
12 Sep 2022 12:18 PM
RNS
Director/PDMR Shareholding
06 Sep 2022 10:08 AM
RNS
Annual Financial Report
05 Sep 2022 07:00 AM
RNS
FY2022 Preliminary Results Announcement
01 Sep 2022 08:42 AM
RNS
Total Voting Rights
30 Aug 2022 07:00 AM
RNS
Acquisition of Med-Pharmex, Inc
27 Jul 2022 12:55 PM
RNS
Holding(s) in Company
25 Jul 2022 05:00 PM
RNS
Director/PDMR Shareholding
21 Jul 2022 07:00 AM
RNS
Results of Placing
20 Jul 2022 05:00 PM
RNS
Retail Offer by PrimaryBid
20 Jul 2022 04:50 PM
RNS
Acquisition and Placing
14 Jul 2022 07:00 AM
RNS
Refinancing Group Facilities - Private Placement
11 Jul 2022 07:00 AM
RNS
Trading Update & Notice of Annual Results
30 Jun 2022 12:09 PM
RNS
Total Voting Rights
13 Jun 2022 10:33 AM
RNS
Director/PDMR Shareholding

Dechra Pharmaceuticals is a global developer and marketor of eterinary pharmaceuticals and related products.

Based in Northwich, England. It was listed on the London Stock Exchange until it was acquired by EQT AB in January 2024.

Dechra share price was listed under the ticker DPH.

UK 100

Latest directors dealings